Sustainability & Climate

Private equity firm SK Capital acquires fruit supplier Brothers International, signaling a major investment in the booming natural and exotic foods market.

With its fiscal 2026 results imminent, STERIS faces high expectations amid market pressures, offering a key indicator for the global healthcare sector.

Integrated Power Services appoints divisional CCOs, signaling a major strategic shift toward unified, lifecycle solutions in a competitive industrial market.

New data shows Synthekine's STK-012 overcomes resistance to standard therapy, offering hope for patients with immune-cold non-small cell lung cancer.

Pursuit will release its Q1 2026 results on May 6. The report will test its strategy and offer a key health check for the global tourism sector.

Remix Therapeutics' first-in-class drug REM-422 targets a rare cancer at its genetic source, with pivotal data set for a major oncology conference.

The advanced materials firm plans a SPAC merger to scale its 'Atomic Armor' nanocoating, aiming to secure U.S. tech sovereignty in AI and defense.

RCOC's Spotlight Awards celebrate local heroes, but behind the honors lies a complex system grappling with workforce shortages and vast unmet needs.

A volunteer army and cutting-edge science converge this May to combat brain cancer, a disease with grim survival rates and a devastating toll on the young.

A new federal partnership and a five-year plan aim to tackle the stubborn rate of serious injuries and fatalities plaguing the construction industry.

Spill control giant FyterTech opens new warehouses, a strategic move to slash delivery times and enhance service in key American industrial regions.

Dizal to unveil late-breaking ZEGFROVY data for NSCLC, plus new findings for drugs tackling resistance and boosting immunotherapy at ASCO 2026.

Michter's Distillery announces its first-ever US★1 Barrel Strength Sour Mash, a potent new expression of a historic and award-winning American whiskey.

As COVID revenues fall, BioNTech bets its future on a robust oncology pipeline. The upcoming Q1 2026 report will reveal the financial health of this pivot.

Talisker Resources triples its Bralorne drill program, aiming to secure future production and explore new gold frontiers in a historic BC mining camp.

As millions seek alternatives to traditional sleep pills, cannabis products are taking over. A #1 ranked gummy reveals the science and trends behind the shift.

Obsidian Therapeutics will unveil pivotal Phase 2 data on OBX-115, an engineered cell therapy that may offer a safer, more potent weapon against melanoma.

New preclinical data for InnoCare's ICP-B794 reveals a wider safety window and power to overcome drug resistance, positioning it as a top contender.

UK biotech Promatix presented a new AI-driven platform at AACR 2026 that finds thousands of new cancer targets, promising safer, more precise 'smart bomb' drugs.

Hospitals are dangerously loud, harming patients and staff. A new modular privacy pod offers a rapid, cost-effective solution to restore quiet and dignity.